Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza | Tenderlake

Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza

Contract Value:
EUR 7M - 7M
Notice Type:
Contract award notice
Published Date:
30 January 2024
Closing Date:
Location(s):
SE SVERIGE (SE Sweden/SVERIGE)
Description:
Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza

This is a procurement divided in five lots to procure services related to support ECDC in the assessment of effectiveness of vaccines against COVID-19 and seasonal influenza among different settings.

This is a procurement divided in 5 lots to procure services related to support ECDC in the assessment of effectiveness of vaccines against COVID-19 and seasonal influenza among different settings.

Awarded to:
Vaccine Effectiveness against COVID-19 and Seasonal Influenza among Patients Presenting to Primary Care Physicians in EU/EEA
Epiconcept, Paris (FR)
Health Protection Surveillance Centre (HPSC), Dublin (IE)
Instituto de Salud Carlos III (ISCIII), Madrid (ES)
Instituto de Salud Publica Y Laboral de Navarra (ISPLN), Pamplona (ES)
Instituto Nacional de Saúde Doutor Ricardo Jorge, I.P (INSA), Lisbon (PT)
Download full details as .pdf
The Buyer:
European Centre for Disease Prevention and Control (ECDC)
CPV Code(s):
85100000 - Health services